The Cost of Biotechnology Regulation in the Philippines

Vista sencilla de ítem
dc.creatorBayer, Jessica C.
dc.creatorNorton, George W.
dc.creatorFalck-Zepeda, Jose Benjamin
dc.date2017-04-01T19:27:15Z
dc.date.accessioned2026-07-09T02:48:02Z
dc.descriptionThis paper identifies direct costs and opportunity costs of bio-safety regulation for four transgenic products in the Philippines: Bt eggplant, Bt rice, ringspot-virus resistant papaya, and virus resistant tomatoes. It finds that direct regulatory costs while significant, are generally smaller than the research costs for technology development. However, both research and regulatory costs are overshadowed by even a relatively brief delay in product release, which may occur due to unexpected regulatory delays.
dc.identifierdoi:10.22004/ag.econ.6507
dc.identifierhttps://ageconsearch.umn.edu/record/6507/files/469973.pdf
dc.identifierhttp://ageconsearch.umn.edu/record/6507
dc.identifier.urihttp://hdl.handle.net/123456789/520251
dc.languageeng
dc.publisher
dc.sourcehttp://ageconsearch.umn.edu/record/6507
dc.titleThe Cost of Biotechnology Regulation in the Philippines
dc.typeText

Archivos

Colecciones

University of Minnesota